No Carolina / NY / Florida
Ph: 561.316.3330

Medical Device News Magazine

Our digital publication offers the latest updates on medical devices. We cover a wide range of topics, including news on clinical trials, product launches, FDA announcements, profiles of device companies, acquisitions, executive movements, non-profit and medical society updates, and more. Our main goal is to provide timely industry information to healthcare professionals, such as medical specialists, executives in the medical device industry, investors, and other allied health professionals. We achieve this objective through various social media platforms and targeted email communications to our subscribers. We invite you to regularly visit our website and explore the advertising opportunities available with us. The publication is a division of PTM Healthcare Marketing, Inc.

Empowering Healthcare Professionals and Investors: The Rise of Next-Generation Medical Devices

Inspira Receives 1st Ever Purchase Order for INSPIRA™ ART100 Systems in the U.S.

Inspira reports the first units are expected to be shipped in Q4 2024. The Purchase Order follows the recent FDA Clearance of the INSPIRA™ ART100.

Movano Health Applies Advanced AI through Deep Learning to Deliver Improved Accuracy of Heart Rate in Motion

Movato Health recently released an engineering accuracy study directed by Movano Health Founder and CTO Michael Leabman, Enhanced Heart Rate in Motion Accuracy with the Evie Ring Using Advanced Deep Learning Algorithms, which demonstrates the value of deep learning integration into heart rate (HR) algorithms for improved accuracy.

― Advertisement ―


― Consider ―


Featuring industry experts in the healthcare field who have come together to share their invaluable insights, perspectives, and opinions. With their wealth of knowledge and experience, these esteemed professionals provide a comprehensive understanding of the latest trends and developments in the healthcare industry.

How Applied Research is Transforming Medical Device Startups | By Hannah Eherenfeldt, Co-founder & CEO of ReSuture

Medical device startups face numerous barriers when trying to penetrate the crowded startup landscape. Fundraising is highly competitive, and many products fail to reach the market due to insufficient funding for research, validation, and testing. The applied research model provides a solution.This industry expert notes this is where the applied research model comes in.

Revolutionizing Healthcare: Latest Biotechnology Innovations

Sphere Fluidics Awarded Gold Accreditation by Investors in People

Dale Levitzke, CEO of Sphere Fluidics, expressed his pride in the achievement: "Receiving the Gold Investors in People Award is a significant milestone for Sphere Fluidics. It recognizes the dedication and hard work of our entire team in creating a workplace where people feel valued, supported, and empowered to reach their full potential. This award is not just a tribute to our HR practices, but a testament to our commitment to nurturing a culture of excellence and continuous improvement."

Jumpcode Genomics and Takara Bio USA Announce Global Patent Partnership

Jumpcode Genomics, a genome technology platform company focused on improving the understanding of human biology, and Takara Bio USA, Inc. (“Takara Bio USA”), a...

CERo Therapeutics Successfully Completes IND-Enabling Toxicology Studies for Lead Compound CER-1236

CERo Therapeutics is continuing IND-enabling activities in preparation for submission of Investigational New Drug Application to FDA

― Advertisement ―


Unveiling the Latest FDA Regulations: What Healthcare Professionals Need to Know

Justice Department and FDA Announce Federal Multi-Agency Task Force to Curb the Distribution and Sale of Illegal E-Cigarettes

"Unauthorized e-cigarettes and vaping products continue to jeopardize the health of Americans – particularly children and adolescents – across the country," said Acting Associate Attorney General Benjamin C. Mizer. "This interagency Task Force is dedicated to protecting Americans by combatting the unlawful sale and distribution of these products. And the establishment of this Task Force makes clear that vigorous enforcement of the tobacco laws is a government-wide priority."

Acquisitions: Unveiling the Future: Medical M&A Insights

Lunit Completes Acquisition of Volpara: Pioneering Next-Level of AI-Driven Cancer Care

"We are thrilled to welcome Volpara into the Lunit family. Today, we take a monumental step towards revolutionizing our approach to cancer care. By combining our strengths, we are creating a formidable alliance in the industry, particularly in the US market. This merger enables us to develop and deliver innovative, life-saving solutions that meet critical needs in cancer diagnostics," said Brandon Suh, CEO of Lunit.

Groundbreaking Developments Shaping Modern Hospitals

Northwell Cardiothoracic Programs Have Nation’s Highest Success Rates

5 Northwell Cardiothoracic Programs (Northwell) include: Long Island Jewish Hospital, Lenox Hill Hospital, South Shore University Hospital, Staten Island University Hospital and the Sandra Atlas Bass Heart Hospital at North Shore University Hospital – received three-star ratings in their respective fields – the highest quality rating possible.

Top Expert Bylines

How Applied Research is Transforming Medical Device Startups | By Hannah Eherenfeldt, Co-founder & CEO of ReSuture

Medical device startups face numerous barriers when trying to penetrate the crowded startup landscape. Fundraising is highly competitive, and many products fail to reach the market due to insufficient funding for research, validation, and testing. The applied research model provides a solution.This industry expert notes this is where the applied research model comes in.

Commercial Success In Global Expansion | Why Compliance and Regulation Don’t Have to Be So Hard | By Phyllis Meng, co-founder and CEO of...

Do compliance and regulation have to be so challenging? Our expert shares their views.

Medical Associations

AI Detects More Breast Cancers with Fewer False Positives

“Population-based screening with mammography reduces breast cancer mortality, but it places a substantial workload on radiologists who must read a large number of mammograms, the majority of which don’t warrant a recall of the patient,” Dr. Lauritzen said. “The reading workload is further compounded when screening programs employ double reading to improve cancer detection and decrease false-positive recalls.” Offers Osteoporosis Awareness and Prevention Resources for Patients

This May,, the authoritative and trusted source on bone and joint health, is joining organizations across the country to raise awareness about prevention strategies that can help reduce one's risk of developing osteoporosis.

Key Clinical Trials Unveiled: Insights for Healthcare Professionals and Savvy Investors

Venus Medtech VenusP-Valve Completed First Implantation in IDE Pivotal Clinical Study in U.S.

The VenusP-Valve PROTEUS STUDY, abbreviated from Evaluation of the PerfoRmance Of The VEnUsP-Valve System in Patients with Native Right Ventricular Outflow Tract (RVOT) Dysfunction, is a prospective multi-center non-randomized interventional study in patients with RVOT disorders comorbid with moderate or greater pulmonary regurgitation. With a target enrollment of 60 subjects, data from this trial will support VenusP-Valve's registration with the U.S. FDA and Japanese Pharmaceuticals and Medical Devices Agency (PMDA).

Pfizer Reports | ELREXFIO ™ Shows Median Overall Survival of More Than Two Years in People with Relapsed or Refractory Multiple Myeloma

“These compelling overall survival data support the clinical benefit ELREXFIO has already demonstrated and its potential to be a transformative treatment option for people with multiple myeloma,” said Roger Dansey, M.D., Chief Development Officer, Oncology, Pfizer. “The latest results from MagnetisMM-3 reinforce the very promising efficacy observed with ELREXFIO in a relapsed or refractory setting, with deep and durable responses and although definitive conclusions cannot be drawn across studies, the longest reported median progression-free survival among B-cell maturation antigen bispecific antibodies.”

Updated Phase 2 CAPTIVATE Study Results

“After more than five years, the CAPTIVATE study findings confirm the sustained benefit of the fixed duration combination of ibrutinib and venetoclax as a first-line treatment for patients living with CLL, including in those with higher risk genomic features,” said Paolo Ghia MD, Università Vita-Salute San Raffaele and IRCCS Ospedale San Raffaele, Milan, Italy, study investigator.‡ “This all-oral, chemotherapy-free, fixed-duration regimen offers eligible patients the advantage of an extended, treatment-free interval while effectively keeping their disease under control.”

Editas Medicine Reports New Safety and Efficacy Data from the RUBY Trial of Reni-cel in 18 Patients with Sickle Cell Disease | Presented at the European Hematology Association (EHA) Annual Congress

“These data confirm the observations from our prior clinical readouts and further support our belief that reni-cel has the potential to be a best-in-class and clinically differentiated, one-time, durable medicine that can provide life-changing clinical benefits to patients,” said Baisong Mei, M.D., Ph.D., Chief Medical Officer, Editas Medicine.

Funding: Unveiling the Latest Medtech Financial Breakthroughs: What You Need to Know

Opthea Limited Successfully Completes Placement and Institutional Component of Entitlement Offer Raising A$171.5 million (US$113.2m¹)

“We appreciate the strong support from our shareholders, and from new investors, who share our belief that sozinibercept has the potential to transform patient outcomes with superior vision gains, which continues to be a significant unmet need in wet AMD,” said Frederic Guerard, PharmD, Chief Executive Officer of Opthea Limited.

InduPro Announces $85 Million Series A Financing

InduPro notes the financing will support the advancement of the first expected clinical product candidate targeting cancer tissue based on the proximity of co-targeted pairs, from preclinical development to an expected IND filing in Q4 2025 for a Phase 1 clinical trial. It will also fuel a pipeline of novel bispecific antibodies and antibody drug conjugates (ADCs) that utilizes protein proximity for identification of novel tumor selective target pairings.

Cutting-Edge Diagnostic Imaging Techniques Revolutionize Medical Diagnostics

VUZE Medical Announces U.S. FDA 510(K) Clearance for Second-Generation Software-Based 3D Guidance System for Spine Surgery

VUZE 2.0 provides much-extended interoperability and functionality; like VUZE 1.0, requires only a 2D C-arm and PC in the OR -- no cameras, markers, references or tool add-ons.

Nicklaus Children’s Health System, Philips Will Provide Innovative Patient & Staff Experience, Helping to Enhance Outcomes for the Smallest of Patients

Philips AI-enabled diagnostic and experiential technologies help put patients at ease while empowering staff with faster, high-quality scans and increased diagnostic confidence.

Arineta Installs First SpotLight™ Duo Scanner

“For patients in need of cardiovascular or cardiothoracic imaging, the SpotLight Duo is the first cardiothoracic CT incorporating all of Arineta’s patient centric technologies. With one heartbeat, we can provide both high-temporal as well as iso-temporal resolution images that can be used for comprehensive cardiac and thoracic CT assessment,” said Doug Ryan, CEO of Arineta

Executives on the Move

Mark Eisner MD, M.P.H. Appointed Chief Medical Officer at Vir Biotechnology

Mark Eisner MD comes from Sonoma Biotherapeutics, Inc., where he most recently held the position of CMO. In this role, he led all development functions which included biometrics, regulatory, clinical science, clinical operations, drug safety, and pharmacology.

Franck Mevellec Appointed Senior Director, Business Development at Asymchem

Franck Mevellec boasts a proven track record of success, having held key positions at industry leaders like Bayer Healthcare (R&D), Teva Pharmaceuticals (portfolio director), Minakem (BD director), and most recently, Seqens (global head of sales). He joins Asymchem with a focus on expanding the company’s footprint across Europe.

Veristat Appoints Dr Gabriela Rosu to Lead Growing Medical Affairs Team

Dr Gabriela Rosu is a seasoned professional with over twenty years of experience in scientific and clinical fields, having significantly contributed to the planning and execution of pivotal activities that have led to the approval and commercialization of groundbreaking therapies.

Sphere Fluidics Appoints Curtis Nicholson as Director of Sales, EMEA, to Support Accelerated Growth in Key Markets

Curtis Nicholson said “I’m thrilled to leverage my experience in strategic sales and driving innovation to take on this exciting role at Sphere Fluidics. I look forward to collaborating with the talented team and accelerating the adoption of our transformative solutions.”

Market Reports

Flow Cytometry Market Surges to $10.3 Billion by 2032, Driven by 9.2% CAGR Growth

The global flow cytometry market, valued at $5.1 billion in 2024, is primed for substantial growth, projected to achieve a remarkable compound annual growth rate (CAGR) of 9.2% over the forecast period, ultimately reaching $10.3 billion by 2032.

Medical Laser Market to Be Worth $17.3 Billion by 2031

According to a new market research report titled, 'Medical Laser Market by Type (Device Type (Solid-state Lasers, Gas Lasers, Dye Lasers, Diode Lasers), Fiber Type (Disposable Laser Fibers, Reusable Laser Fibers)), Application (Device, Fiber), and Geography—Global Forecast to 2031,' the medical laser market is projected to reach $17.3 billion by 2031, at a CAGR of 17.6% from 2024–2031.

Ambulatory EHR Market to be Worth $7.84 billion by 2031 – Exclusive Report

Ambulatory electronic health record (EHR) software is designed for outpatient care settings, enabling medical professionals to access a patient's complete medical history stored in an electronic format.

Nurse's Corner Unveils Next-Generation Talent Marketplace To Revolutionize Healthcare Hiring

With a deep understanding of nurses’ behavior and skills, utilizes next-generation technology, candidate data, and completed courses to deliver personalized job matches. This approach enables recruiters to find candidates who not only meet their organization’s needs but also fit its culture.

Hospice Nurse with 3 Million Social Media Followers Partners with Medical Device Company

Hospice Nurse Julie and Hospi Corporation Team Up to Raise Awareness about the Macy Catheter


A Must-Have Medical Equipment List For Ambulatory Care Facilities

Ambulatory care facilities cover a broad range of outpatient services. Discover the essential pieces of medical equipment every provider must have.

Marketing for Doctors:10 Best Proven Activities for Your Practice

In today's digital world, doctors cannot rely on traditional marketing methods alone to attract and retain patients. Doctors in Houston must utilize digital marketing...

― Advertisement ―


Unlocking Success in Medical Business

The D-Actor 100 from STORZ Medical: Revolutionizing Pressure Wave Therapy Standards

The D-Actor 100 by STORZ Medical stands out in this field and is recognized as a leading device for healthcare professionals seeking effective treatment outcomes. This technology utilizes pressure waves to stimulate the body's natural healing processes, improving circulation and cell regeneration through microtrauma in targeted tissues.

Healthcare Professionals / Career Corner

6 Tips For Mitigating Risks Associated With Running A Med Spa

Running a med spa is a lucrative way to make people look and feel better, but like everything else, it has significant risks.

9 Ways to Land Higher Roles in Healthcare

There are several ways to ensure speedy career advancements to achieve higher roles in healthcare. The following are some strategies to achieve this goal.

Health / Lifestyle

Articles of Interest

Join Our Family

Receive a recap of news at the end of every week. We do not sell our lists!

By using this website you agree to accept Medical Device News Magazine Privacy Policy